Literature DB >> 2464797

Characterization of single base substitutions in edited apolipoprotein B transcripts.

G E Tennyson1, C A Sabatos, T L Eggerman, H B Brewer.   

Abstract

Mature RNA transcripts from a single eukaryotic gene may contain different nucleotide sequences, ranging from alternately spliced exons to transcripts from separate alleles differing by only one base. Our laboratory and others have recently reported another class of RNA sequence differences, occurring in transcripts from the single copy apolipoprotein B (apoB) gene. A unique RNA editing mechanism allows expression of the CAA glutamine codon encoded by the apoB gene at nucleotide 6666, or terminates translation by the introduction of a premature UAA translational stop codon. In this study, we used the polymerase chain reaction (PCR) to amplify and characterize edited apoB RNA transcripts differing by a single nucleotide. Amplification and sequence analysis from small quantities of total RNA will facilitate the study of RNA editing and transcription in general.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464797      PMCID: PMC331612          DOI: 10.1093/nar/17.2.691

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  RNA amplification with transcript sequencing (RAWTS).

Authors:  G Sarkar; S S Sommer
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

2.  Nucleotide sequence of novel cDNAs generated by alternative splicing of a rat thyroid hormone receptor gene transcript.

Authors:  T Mitsuhashi; G Tennyson; V Nikodem
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

3.  Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone.

Authors:  T Mitsuhashi; G E Tennyson; V M Nikodem
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Developmental coordinate expression of triacylglycerol and small molecular weight apoB synthesis and secretion by rat hepatocytes.

Authors:  R A Coleman; E B Haynes; T M Sand; R A Davis
Journal:  J Lipid Res       Date:  1988-01       Impact factor: 5.922

5.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

Authors:  L M Powell; S C Wallis; R J Pease; Y H Edwards; T J Knott; J Scott
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

6.  Apolipoprotein B-100 is the major form of this apolipoprotein secreted by human intestinal Caco-2 cells.

Authors:  D M Lee; N Dashti; T Mok
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

7.  Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Authors:  E S Kawasaki; S S Clark; M Y Coyne; S D Smith; R Champlin; O N Witte; F P McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes.

Authors:  J D Sparks; C E Sparks; M Bolognino; A M Roncone; T K Jackson; J M Amatruda
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Extensive editing of the cytochrome c oxidase III transcript in Trypanosoma brucei.

Authors:  J E Feagin; J M Abraham; K Stuart
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

View more
  2 in total

1.  A termination codon is created by RNA editing in the petunia atp9 transcript.

Authors:  H Wintz; M R Hanson
Journal:  Curr Genet       Date:  1991-01       Impact factor: 3.886

Review 2.  RNA editing and the mitochondrial cryptogenes of kinetoplastid protozoa.

Authors:  L Simpson; J Shaw
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.